Valeant Pharms Intl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VALEANT PHARMS INTL, and when can generic versions of VALEANT PHARMS INTL drugs launch?
VALEANT PHARMS INTL has three approved drugs.
There are six US patents protecting VALEANT PHARMS INTL drugs.
There are forty-four patent family members on VALEANT PHARMS INTL drugs in twelve countries.
Summary for Valeant Pharms Intl
| International Patents: | 44 |
| US Patents: | 6 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 3 |
Drugs and US Patents for Valeant Pharms Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharms Intl | CUPRIMINE | penicillamine | CAPSULE;ORAL | 019853-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
| Valeant Pharms Intl | GIAZO | balsalazide disodium | TABLET;ORAL | 022205-001 | Feb 3, 2012 | DISCN | Yes | No | 7,452,872 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Valeant Pharms Intl | COLAZAL | balsalazide disodium | CAPSULE;ORAL | 020610-001 | Jul 18, 2000 | AB | RX | Yes | Yes | 7,452,872*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Valeant Pharms Intl | GIAZO | balsalazide disodium | TABLET;ORAL | 022205-001 | Feb 3, 2012 | DISCN | Yes | No | 9,192,616 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Valeant Pharms Intl | CUPRIMINE | penicillamine | CAPSULE;ORAL | 019853-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Valeant Pharms Intl | GIAZO | balsalazide disodium | TABLET;ORAL | 022205-001 | Feb 3, 2012 | DISCN | Yes | No | 7,625,884 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Valeant Pharms Intl | GIAZO | balsalazide disodium | TABLET;ORAL | 022205-001 | Feb 3, 2012 | DISCN | Yes | No | 8,497,256 | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Valeant Pharms Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Valeant Pharms Intl | COLAZAL | balsalazide disodium | CAPSULE;ORAL | 020610-001 | Jul 18, 2000 | 4,412,992*PED | ⤷ Subscribe |
| Valeant Pharms Intl | GIAZO | balsalazide disodium | TABLET;ORAL | 022205-001 | Feb 3, 2012 | 6,197,341 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for VALEANT PHARMS INTL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 1.1 g | ➤ Subscribe | 2013-11-05 |
International Patents for Valeant Pharms Intl Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 101610670 | ⤷ Subscribe |
| Japan | 2013525440 | ⤷ Subscribe |
| China | 101247812 | ⤷ Subscribe |
| New Zealand | 593132 | ⤷ Subscribe |
| European Patent Office | 2586427 | ⤷ Subscribe |
| China | 105267226 | ⤷ Subscribe |
| Japan | 2010509326 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
